Specifically, CD80 and CD86 were higher in tumour-residing CCR7+ DCs, confirmed at a protein level, while Icosl was significantly higher in migrated CCR7+ DCs in the dLN (Fig. 2g, h, Supplementary Fig. 4b). This evidence concerns the gene CD80 and neoplasm.